Lab-made mild virus mimics Covid-19, can aid drug, vaccine discovery: Study
Scientists
have genetically modified a "mild
virus" which generates antibodies in humans just like the novel
coronavirus, but without causing severe disease, an advance which they say will
enable more labs across the world to safely test drugs and vaccine candidates
against COVID-19.
The
researchers from the Washington University School of Medicine in St Louis in
the US engineered the mildly infecting vesicular stomatitis virus (VSV) which
virologists widely use in experiments by swapping one of its genes for one from
the novel coronavirus SARS-CoV-2.
According
to the study, published in the journal Cell Host & Microbe, the resulting
hybrid virus infects cells, and is recognised by antibodies in humans just like
SARS-CoV-2, but can be handled under ordinary laboratory safety conditions.
Since the
novel coronavirus spreads easily via aerosols, and is potentially deadly, the
scientists said it is studied only under high-level biosafety conditions. Read More
Comments
Post a Comment